These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3031122)
21. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). Buxton EC; Yao W; Lane NE J Clin Endocrinol Metab; 2004 Jul; 89(7):3332-6. PubMed ID: 15240611 [TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381 [TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of parathyroid hormone/parathyroid hormone-related peptide receptor in cultured astrocytes. Hashimoto H; Aino H; Ogawa N; Nagata S; Baba A Biochem Biophys Res Commun; 1994 Apr; 200(2):1042-8. PubMed ID: 8179580 [TBL] [Abstract][Full Text] [Related]
24. Immunological properties of synthetic human parathyroid hormone: effect of deamidation at position 76. Gleed JH; Hendy GN; Kimura T; Sakakibara S; O'Riordan JL Bone Miner; 1987 Aug; 2(5):375-82. PubMed ID: 2464379 [TBL] [Abstract][Full Text] [Related]
25. Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34. Whitfield JF; Isaacs RJ; Chakravarthy B; Maclean S; Morley P; Willick G; Divieti P; Bringhurst FR J Bone Miner Res; 2001 Mar; 16(3):441-7. PubMed ID: 11277261 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of homologous and heterologous regulation of parathyroid hormone receptors in the rat osteosarcoma cell line UMR-106. Mitchell J; Goltzman D Endocrinology; 1990 May; 126(5):2650-60. PubMed ID: 2158432 [TBL] [Abstract][Full Text] [Related]
27. Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. Takasu H; Guo J; Bringhurst FR J Bone Miner Res; 1999 Jan; 14(1):11-20. PubMed ID: 9893061 [TBL] [Abstract][Full Text] [Related]
28. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Podbesek R; Edouard C; Meunier PJ; Parsons JA; Reeve J; Stevenson RW; Zanelli JM Endocrinology; 1983 Mar; 112(3):1000-6. PubMed ID: 6822201 [TBL] [Abstract][Full Text] [Related]
29. Bioactivity of amino terminal fragments of parathyroid hormone and parathyroid hormone related peptide in rat kidney slices: no effect of dietary phosphate deprivation. Prince RL; Dick IM; Kent GN Horm Metab Res; 1990 Nov; 22(11):569-72. PubMed ID: 2177031 [TBL] [Abstract][Full Text] [Related]
30. [Initial experiences with substitution treatment of hypoparathyroidism with synthetic human parathyroid hormone]. Stögmann W; Bohrn E; Woloszczuk W Monatsschr Kinderheilkd; 1990 Mar; 138(3):141-6. PubMed ID: 2162006 [TBL] [Abstract][Full Text] [Related]
31. Rapid increase in bone mineral density in a child with osteoporosis and autoimmune hypoparathyroidism treated with PTH 1-34. Koch CA Exp Clin Endocrinol Diabetes; 2001; 109(6):350-4. PubMed ID: 11571675 [TBL] [Abstract][Full Text] [Related]
32. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650 [TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265 [TBL] [Abstract][Full Text] [Related]
34. Human parathyroid hormone: synthesis and chemical, biological, and immunological evaluation of the carboxyl-terminal region. Rosenblatt M; Segre GV; Tregear GW; Shepard GL; Tyler GA; Potts JT Endocrinology; 1978 Sep; 103(3):978-84. PubMed ID: 744126 [TBL] [Abstract][Full Text] [Related]
35. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Divieti P; John MR; Jüppner H; Bringhurst FR Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Schneider HG; Michelangeli VP; Frampton RJ; Grogan JL; Ikeda K; Martin TJ; Findlay DM Endocrinology; 1992 Sep; 131(3):1383-9. PubMed ID: 1324161 [TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans. Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. Hock JM; Fonseca J; Gunness-Hey M; Kemp BE; Martin TJ Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976 [TBL] [Abstract][Full Text] [Related]
39. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Sone T; Fukunaga M; Ono S; Nishiyama T Miner Electrolyte Metab; 1995; 21(1-3):232-5. PubMed ID: 7565456 [TBL] [Abstract][Full Text] [Related]